| Item Type | Name |
|
Academic Article
|
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.
|
|
Concept
|
Mesothelioma
|
|
Concept
|
Survival Rate
|
|
Concept
|
Receptors, Interleukin-17
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Humans
|
|
Concept
|
Gonanes
|
|
Concept
|
Benchmarking
|
|
Concept
|
Cell Movement
|
|
Concept
|
Organic Cation Transport Proteins
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Drug Screening Assays, Antitumor
|
|
Concept
|
Doxycycline
|
|
Concept
|
Cancer Care Facilities
|
|
Concept
|
Integrin beta1
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex
|
|
Concept
|
CD27 Ligand
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Receptor, Notch1
|
|
Concept
|
Urologic Neoplasms
|
|
Concept
|
Interferon Regulatory Factor-3
|
|
Concept
|
Inhibitory Concentration 50
|
|
Concept
|
Cysteine Proteinase Inhibitors
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Inflammation
|
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Vesicular Transport Proteins
|
|
Concept
|
Cytokines
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Tandem Mass Spectrometry
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Neutrophils
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Nucleoside-Phosphate Kinase
|
|
Concept
|
Receptors, Interleukin-1
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
CD57 Antigens
|
|
Concept
|
Integrases
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Animals, Newborn
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
CD8 Antigens
|
|
Concept
|
Incidence
|
|
Concept
|
CD4 Antigens
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Oncogenes
|
|
Concept
|
Texas
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
|
Concept
|
CD40 Antigens
|
|
Concept
|
Receptors, Transforming Growth Factor beta
|
|
Concept
|
Myosins
|
|
Concept
|
Lentivirus
|
|
Concept
|
Lysosomes
|
|
Concept
|
Macaca
|
|
Concept
|
Research Design
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Carcinoma, Lewis Lung
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Artificial Intelligence
|
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Animals
|
|
Concept
|
Histamine
|
|
Concept
|
Molecular Dynamics Simulation
|
|
Concept
|
Random Allocation
|
|
Concept
|
ADP-ribosyl Cyclase 1
|
|
Concept
|
Receptors, Lysophosphatidic Acid
|
|
Concept
|
Macrophages
|
|
Concept
|
Ataxia Telangiectasia
|
|
Concept
|
Tretinoin
|
|
Concept
|
Cricetinae
|
|
Concept
|
Mice, Inbred NOD
|
|
Concept
|
Receptors, Histamine
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Liposomes
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Enzyme Stability
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Membrane Fusion
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Models, Genetic
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Metabolomics
|
|
Concept
|
Tumor Necrosis Factor Receptor Superfamily, Member 9
|
|
Concept
|
Immunotherapy, Adoptive
|
|
Concept
|
Luciferases
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Acetylation
|
|
Concept
|
Binding Sites
|
|
Concept
|
Semliki forest virus
|
|
Concept
|
Amino Acid Oxidoreductases
|
|
Concept
|
Microscopy
|
|
Concept
|
Sodium-Potassium-Exchanging ATPase
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Disease Progression
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Chromosomal Instability
|
|
Concept
|
Cadherins
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Microscopy, Electron, Transmission
|
|
Concept
|
Carcinoma, Basal Cell
|
|
Concept
|
rho GTP-Binding Proteins
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Calcium
|
|
Concept
|
Platelet Factor 4
|
|
Concept
|
DNA Copy Number Variations
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Mice, Nude
|
|
Concept
|
4-Nitroquinoline-1-oxide
|
|
Concept
|
Benzocycloheptenes
|
|
Concept
|
Neoplastic Cells, Circulating
|
|
Concept
|
Mice, Inbred Strains
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Fluorodeoxyglucose F18
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Kidney Neoplasms
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Rats
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
PPAR gamma
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Mouth Neoplasms
|
|
Concept
|
Models, Molecular
|
|
Concept
|
Benzamides
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
HLA Antigens
|
|
Concept
|
Fibrosis
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Rats, Wistar
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Genes, src
|
|
Concept
|
Fusion Proteins, bcr-abl
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Carcinoma, Neuroendocrine
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Myocardium
|
|
Concept
|
Carcinoma, Large Cell
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Carcinogens
|
|
Concept
|
Mice
|
|
Concept
|
Synaptotagmins
|
|
Concept
|
Mesoderm
|
|
Concept
|
DNA Primers
|
|
Concept
|
Desoxycorticosterone
|
|
Concept
|
Cyclin-Dependent Kinase 4
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Models, Biological
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Linear Models
|
|
Concept
|
Immunomodulation
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Receptors, Purinergic P1
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Databases as Topic
|
|
Concept
|
Receptors, Notch
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
United States
|
|
Concept
|
Phenols
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Carcinoma, Intraductal, Noninfiltrating
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Skin Neoplasms
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Chemokine CXCL10
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Risk Factors
|
|
Concept
|
MAP Kinase Kinase 4
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
Receptor, ErbB-3
|
|
Concept
|
Carcinoma, Ductal, Breast
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Hyperplasia
|
|
Concept
|
Arthritis
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Actin Cytoskeleton
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
Claudins
|
|
Concept
|
Melanoma
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Genes, erbB
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
rab GTP-Binding Proteins
|
|
Concept
|
Genes, ras
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
CD3 Complex
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
HLA-A2 Antigen
|
|
Concept
|
Thoracic Surgery, Video-Assisted
|
|
Concept
|
Loss of Heterozygosity
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Cell Separation
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Adenosine
|
|
Concept
|
Monocytes
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Protein Structure, Secondary
|
|
Concept
|
Immunologic Memory
|
|
Concept
|
Matrix Metalloproteinases
|
|
Academic Article
|
Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography.
|
|
Academic Article
|
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments.
|
|
Academic Article
|
Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
|
|
Academic Article
|
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma.
|
|
Academic Article
|
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
|
|
Academic Article
|
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
|
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Discoidin Domain Receptor 2
|
|
Concept
|
AC133 Antigen
|
|
Concept
|
Kelch-Like ECH-Associated Protein 1
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
Serrate-Jagged Proteins
|
|
Concept
|
Jagged-1 Protein
|
|
Concept
|
Jagged-2 Protein
|
|
Concept
|
Protein Domains
|
|
Concept
|
Hepatitis A Virus Cellular Receptor 2
|
|
Concept
|
Gain of Function Mutation
|
|
Concept
|
Circulating Tumor DNA
|
|
Concept
|
Discs Large Homolog 1 Protein
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Ipilimumab
|
|
Concept
|
Mice, 129 Strain
|
|
Concept
|
Th17 Cells
|
|
Concept
|
GPI-Linked Proteins
|
|
Concept
|
B7 Antigens
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Carcinogenesis
|
|
Concept
|
Multimodal Imaging
|
|
Concept
|
Adenocarcinoma in Situ
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Datasets as Topic
|
|
Academic Article
|
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer.
|
|
Academic Article
|
PI4KIII? is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma.
|
|
Academic Article
|
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
|
|
Academic Article
|
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.
|
|
Academic Article
|
Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
|
|
Academic Article
|
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
|
|
Academic Article
|
Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
|
|
Academic Article
|
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
|
|
Academic Article
|
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
|
|
Academic Article
|
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1.
|
|
Academic Article
|
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response.
|
|
Academic Article
|
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
|
|
Academic Article
|
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
|
|
Academic Article
|
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
|